On the Record · Clover Health Investments
Clover Health Investments acquisitions, on the record
The businesses Clover Health Investments bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.
Deals its annual reports describe
| Business | Deal | When | Value |
|---|---|---|---|
Juxly, LLCWord for word“The reporting unit goodwill was established in connection with the acquisition of Medical Services Professionals of New Jersey, LLC (“MSPNJ”) and Principium Health, LLC (“Principium”) on February 28, 2019 and Juxly, LLC on November 14, 2022.” 10-K for 2023 | acquisition | November 14, 2022 | — |
Character Biosciences, Inc.Word for word“Acquisition of Character Biosciences, Inc. Series A preferred shares — ( 250 ) — Net cash provided by (used in) investing activities 140,013 95,133 ( 435,447 ).” 10-K for 2023 | acquisition | — | 250 |
Business acquired in 2022 (cash flow line "Acquisition of business, net of cash acquired")Word for word“Acquisition of business, net of cash acquired — ( 16,200 ) — Purchases of property and equipment ( 584 ) ( 4,467 ) ( 723 ).” 10-K for 2023 | acquisition | — | 16,200 |
Union Life Labor Insurance Company (Ullico)Word for word“Clover acquired certain policies and related reinsurance agreements with the purchase of stock of Union Life Labor Insurance Company (Ullico) in April 2016.” 10-K for 2023 | acquisition | April 2016 | — |
Legacy Clover (2021 Business Combination with Social Capital Hedosophia Holdings Corp. III)Word for word“Pursuant to the Merger Agreement, on January 7, 2021, Asclepius Merger Sub Inc., a Delaware corporation and a newly formed, wholly-owned subsidiary of SCH ("Merger Sub"), merged with and into Legacy Clover.” 10-K for 2023 | merger | January 7, 2021 | — |
Legacy CloverWord for word“Pursuant to the Merger Agreement, on January 7, 2021, Asclepius Merger Sub Inc., a Delaware corporation and a newly formed, wholly-owned subsidiary of SCH ("Merger Sub"), merged with and into Legacy Clover.” 10-K for 2024 | merger | January 7, 2021 | — |
| Fiscal year ended | Cash paid for acquisitions (net of cash acquired) | Goodwill from acquisitions |
|---|---|---|
| 2019-12-31 | $1.2 million | — |
| 2020-12-31 | $0 | — |
| 2021-12-31 | $0 | $0 |
| 2022-12-31 | $16.2 million | $10.5 million |
| 2023-12-31 | $0 | — |
| 2024-12-31 | $0 | — |
Deal filings since 2016
- 2023-03-17 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2021-01-12 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2021-01-12 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
- 2020-12-10 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2020-10-06 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
Read from Clover Health Investments’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-27. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.